Nobiletin alleviates cisplatin-induced ototoxicity via activating autophagy and inhibiting NRF2/GPX4-mediated ferroptosis

Wenao Song,Li Zhang,Xiaolin Cui,Rongrong Wang,Jingyu Ma,Yue Xu,Yan Jin,Dawei Wang,Zhiming Lu

DOI: https://doi.org/10.1038/s41598-024-55614-4

IF: 4.6

2024-04-04

Scientific Reports

Abstract:Nobiletin, a citrus polymethoxy flavonoid with antiapoptotic and antioxidative properties, could safeguard against cisplatin-induced nephrotoxicity and neurotoxicity. Cisplatin, as the pioneer of anti-cancer drug, the severe ototoxicity limits its clinical applications, while the effect of nobiletin on cisplatin-induced ototoxicity has not been identified. The current study investigated the alleviating effect of nobiletin on cisplatin-induced ototoxicity and the underlying mechanisms. Apoptosis and ROS formation were evaluated using the CCK-8 assay, Western blotting, and immunofluorescence, indicating that nobiletin attenuated cisplatin-induced apoptosis and oxidative stress. LC3B and SQSTM1/p62 were determined by Western blotting, qPCR, and immunofluorescence, indicating that nobiletin significantly activated autophagy. Nobiletin promoted the nuclear translocation of NRF2 and the transcription of its target genes, including Hmox1 , Nqo1 , and ferroptosis markers ( Gpx4 , Slc7a11 , Fth , and Ftl ), thereby inhibiting ferroptosis. Furthermore, RNA sequencing analysis verified that autophagy, ferroptosis, and the NRF2 signaling pathway served as crucial points for the protection of nobiletin against ototoxicity caused by cisplatin. Collectively, these results indicated, for the first time, that nobiletin alleviated cisplatin-elicited ototoxicity through suppressing apoptosis and oxidative stress, which were attributed to the activation of autophagy and the inhibition of NRF2/GPX4-mediated ferroptosis. Our study suggested that nobiletin could be a prospective agent for preventing cisplatin-induced hearing loss.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper attempts to address whether nobiletin can alleviate cisplatin-induced ototoxicity and explore its potential molecular mechanisms.

Specifically, cisplatin is a widely used anticancer drug, but its severe ototoxicity limits its clinical application. Ototoxicity manifests as bilateral, symmetrical, irreversible, and cumulative sensorineural hearing loss. Studies have found that nobiletin has antioxidant and anti-apoptotic properties, and previous research has shown that it can alleviate cisplatin-induced nephrotoxicity and neurotoxicity. However, there have been no reports on whether nobiletin can alleviate cisplatin-induced ototoxicity and its mechanisms of action.

Therefore, this paper aims to investigate the protective effects of nobiletin on cisplatin-induced ototoxicity and reveal the underlying molecular mechanisms, including autophagy activation and ferroptosis inhibition. The results indicate that nobiletin alleviates cisplatin-induced ototoxicity by inhibiting apoptosis and oxidative stress, and these effects are related to autophagy activation and NRF2/GPX4-mediated ferroptosis inhibition.